GSK highlights new findings on Dementia and Alzheimer’s Disease at AAIC 2025, building on leadership

GSK highlights new findings on Dementia and Alzheimer’s Disease at AAIC 2025, building on leadership in immunology and inflammation

Real-world data shows an association between Recombinant Zoster Vaccine (RZV) and potential reduced risk of dementia.

RSS Hunter • Jul 29, 2025